4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000013
Options or other derivatives
- Director acquired 32,900 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Karydas Daphne Director | 2025-02-13 | Grant or award · Stock Option | +32,900 | 32,900 | D | ||
Loading xslF345X05/wk-form4_1740441514.xml…